LCA5 anticorps (N-Term)
Aperçu rapide pour LCA5 anticorps (N-Term) (ABIN632308)
Antigène
Voir toutes LCA5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- LCA5 antibody was raised against the N terminal of LCA5
-
Purification
- Affinity purified
-
Immunogène
- LCA5 antibody was raised using the N terminal of LCA5 corresponding to a region with amino acids FSLQKLKEISEARHLPERDDLAKKLVSAELKLDDTERRIKELSKNLELST
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
LCA5 Blocking Peptide, (ABIN938457), is also available for use as a blocking control in assays to test for specificity of this LCA5 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LCA5 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LCA5 (Leber Congenital Amaurosis 5 (LCA5))
-
Autre désignation
- LCA5
-
Sujet
- LCA5 is a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Mutations in this gene cause Leber congenital amaurosis type V. Alternative splicing results in two transcript variants.
-
Poids moléculaire
- 80 kDa (MW of target protein)
Antigène
-